Categories:
North Dakota Medicaid Drug Use Review Board
Wednesday, December 7, 2022
1 to 4 p.m. Central Time
In-Person Information
Conference Room 210/212, 2nd Floor, Judicial Wing, State Capitol
600 E. Boulevard Ave., Bismarck
Virtual Information
Join virtually: Click here to join the meeting
Join by phone: 701-328-0950, Conference ID: 278 214 277#
Agenda
1. Administrative items
- DHS announcements
2. Old business
- Review and approval of September 2022 meeting minutes
- Budget update
- Review top 25 drugs for the third quarter of 2022
- Prior authorization/PDL update
- Update to Prurigo Nodularis (Dupixent)
- Update to Endometriosis Pain (Myfembree)
- Update to Hematopoietic Syndrome of Acute Radiation Syndrome (NPlate)
- Second Review of Amyloidosis (Vyndaqel, Vyndamax, Tegsedi)
- Second Review of Amyotrophic Lateral Sclerosis (Radicava)
- Second Review of Chelating Agents (Ferriprox)
- Treatment follow up questions for Eosinophilic Esophagitis
- Annual prior authorization review of prior authorization forms and criteria
3. New business
- Discussion of RDUR response letter
- Retrospective DUR profile review update
- Retrospective DUR criteria recommendations
- Upcoming meeting date/agenda
Next meeting is March 1, 2023
4. Adjourn
Individuals with disabilities who need accommodations, including appropriate auxiliary aids to participate, can contact Stacey Koehly at 701-328-4807, toll-free 800-755-2604, 711 (TTY) or skoehly@nd.gov.
Date Posted: Jan. 20, 2022
Date Revised: Dec. 6, 2022 (agenda/meeting details added)